Courts' Misapplication Of FDA Preemption Policy Creates Quandary For Drug Producers

Working Papers

January 12, 2007

Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

By James M. Wood,a Partner in the Oakland office of the law firm Reed Smith LLP and Claire A. Hass, University of California, Hastings College of the Law '07.

Legal Opinion Letters

March 24, 2006

Advertising And Preemption Under FDA’s New Drug Labeling Rule

By Tish E. Pahl, a principal with Olsson, Frank and Weeda, P.C.

Counsel’s Advisories

January 27, 2006

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

By James Dabney Miller, a partner in the Washington, D.C. office of the law firm King & Spalding LLP.

Leading Legal Scholar John Yoo of UC Berkeley Law Joins WLF’s Legal Policy Advisory Board

Robinhood Markets, Inc. v. Sodha

Authors of WLF Working Paper Receive Burton Awards for Distinguished Legal Writing

Legal Backgrounders

Courts’ Misapplication Of FDA Preemption Policy Creates Quandary For Drug Producers

Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

Advertising And Preemption Under FDA’s New Drug Labeling Rule

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

Featured

Leading Legal Scholar John Yoo of UC Berkeley Law Joins WLF’s Legal Policy Advisory Board

Featured Case

Robinhood Markets, Inc. v. Sodha

Featured

Authors of WLF Working Paper Receive Burton Awards for Distinguished Legal Writing

Legal Backgrounders

Courts’ Misapplication Of FDA Preemption Policy Creates Quandary For Drug Producers

Related Content

Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

Advertising And Preemption Under FDA’s New Drug Labeling Rule

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims